These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6000363)

  • 21. [Structure-action relations of monoamine oxidase inhibitors].
    Matthies H; Fähse C; Lietz W; Jassmann E
    Acta Biol Med Ger; 1967; 19(3):447-61. PubMed ID: 5591162
    [No Abstract]   [Full Text] [Related]  

  • 22. Brain tryptamine and the effects of drugs.
    Saavedra JM; Axelrod J
    Adv Biochem Psychopharmacol; 1974; 10():135-9. PubMed ID: 4276952
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of hyperbaric oxygenation on cerebral amines in suckling rats: changes induced with MAO antagonists].
    Porta L; Barbarani V
    Boll Soc Ital Biol Sper; 1968 Jul; 44(13):1039-43. PubMed ID: 5727400
    [No Abstract]   [Full Text] [Related]  

  • 24. [3,4,5-trimethoxybenzoic acid hydrazides with anti-monoamine-oxidase activity].
    Mazzone G; Arrigo Reina R
    Boll Soc Ital Biol Sper; 1970 Dec; 46(24):1044-5. PubMed ID: 5519866
    [No Abstract]   [Full Text] [Related]  

  • 25. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism of inhibition of beef liver mitochondrial monoamine oxidase by iproniazid.
    Gomes B
    Indian J Biochem Biophys; 1983 Apr; 20(2):96-9. PubMed ID: 6671669
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serotoninergic syndrome after combining tramadol and iproniazid].
    de Larquier A; Vial T; Bréjoux G; Descotes J
    Therapie; 1999; 54(6):767-8. PubMed ID: 10709455
    [No Abstract]   [Full Text] [Related]  

  • 28. [Behavioral modifications observed following repeated administrations of monoamine oxidase inhibitors].
    Goldwurm GF; Torrigiani G
    Riv Neurobiol; 1964; 10(4):Suppl:1099-106. PubMed ID: 5827089
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anti-inflammatory effect of iprazid and DG-2].
    Riabukha TK
    Farmakol Toksikol; 1970; 33(2):199-201. PubMed ID: 5448562
    [No Abstract]   [Full Text] [Related]  

  • 30. Activation of brain 5-HT neurons by two alpha-methylated tryptamine derivatives.
    Arai Y; Tadano T; Yonezawa A; Fujita T; Kinemuchi H; Kisara K
    Prog Brain Res; 1995; 106():269-75. PubMed ID: 8584663
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of 1-(indolyl-2-carbonyl)-2-alkyl-hydrazine derivatives on amine levels and monoamine oxidase activity in rat tissues.
    Vega P; Borrell S
    Biochem Pharmacol; 1972 Oct; 21(19):2571-5. PubMed ID: 4661618
    [No Abstract]   [Full Text] [Related]  

  • 32. Vascular hypersensitivity and potentiation of catecholamines induced by monoamine oxidase inhibition.
    Balourdas TA
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):275-88. PubMed ID: 5926870
    [No Abstract]   [Full Text] [Related]  

  • 33. The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
    Dandiya PC; Bhargava LP
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):157-67. PubMed ID: 5709781
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on the analgetic effects of MAO inhibitors].
    Fähse C; Matthies H
    Acta Biol Med Ger; 1971; 26(6):1215-21. PubMed ID: 5153309
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of iproniazid, chlorpromazine and methiothepin on DMT-induced changes in body temperature, pupillary dilatation, blood pressure and EEG in the rabbit.
    Moore RH; Demetriou SK; Domino EF
    Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):64-72. PubMed ID: 1057382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tryptamine: potentiation of its hyperthermic effect in rabbits by various monoamine oxidase inhibitors.
    Quock RM
    Pharmacol Res Commun; 1981 Mar; 13(3):281-6. PubMed ID: 6111091
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of serotonin on the volume rate of coronary blood circulation in cats under isolated conditions in relation to monoamine oxidase inhibitors].
    Gilev AP; Solonenko EL
    Farmakol Toksikol; 1967; 30(6):678-81. PubMed ID: 5598434
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of monoamine oxidase inhibitors on the tryptamine content of the rat brain and on "tryptamine convulsions"].
    Popov N; Lietz W; Matthies H
    Acta Biol Med Ger; 1967; 18(2):233-44. PubMed ID: 5586804
    [No Abstract]   [Full Text] [Related]  

  • 39. Species differences in the cardiac effects of a monoamine oxidase inhibitor.
    GOLDBERG ND; SHIDEMAN FE
    J Pharmacol Exp Ther; 1962 May; 136():142-51. PubMed ID: 13899710
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoamine oxidase and head-twitch response in mice. Mechanisms of alpha-methylated substrate derivatives.
    Nakagawasai O; Arai Y; Satoh SE; Satoh N; Neda M; Hozumi M; Oka R; Hiraga H; Tadano T
    Neurotoxicology; 2004 Jan; 25(1-2):223-32. PubMed ID: 14697897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.